Eli Lilly and Company (NYSE: LLY) today announced that the U.S. Food and Drug Administration (FDA) has granted approval to ...

Kuros Biosciences announces enrollment of first patient in ASTRA study – A global, prospective, randomized, multi-center clinical trial in foot and ankle fusion Schlieren (Zürich), Switzerland, ...

New research from a randomized clinical trial provides the strongest long-term evidence yet comparing partial (PKR) and total (TKR) knee replacements for patients with osteoarthritis. Published in The ...

Company plans to discuss results and regulatory pathway of IGV-001 with U.S. FDA in the coming months -- Imvax, Inc., a clinical-stage biotechnology company developing personalized, whole ...

A randomized clinical trial found that among people with a history of Atrial fibrillation (AFib) or related rhythm issues, drinking at least one cup of caf ...

GBM Program Update and Phase 2 Plans Approximately 50% of patients with glioblastoma (GBM) present with an oncogenic EGFR alteration that can be targeted by silevertinib; each year approximately 7,000 ...

Examine the rise of personalized and biomarker-driven therapies, the logistical challenges of rare patient populations, and ...

Phase 1 results show that SUL-238 is safe, well-tolerated, and demonstrates favorable pharmacokinetics with high CSF ...

Cannabis is increasingly being used to help reduce or stop the misuse of alcohol, a harm reduction strategy driving a popular ...